BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea · Delayed Price · Currency is KRW 8,870.00
+50.00 (0.57%)
At close: Sep 3, 2026
BIO-FD&C Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 78,261 | 137,392 | 120,175 | 122,783 | 147,827 | - | |
Market Cap Growth | -50.93% | 14.33% | -2.13% | -16.94% | - | - |
Enterprise Value | 23,010 | 86,555 | 77,523 | 84,326 | 109,227 | - |
Last Close Price | 9000.00 | 15800.00 | 13820.00 | 14120.00 | 17000.00 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.00 | 20.61 | 26.70 | 21.98 | 34.10 | - |
Forward PE | - | 15.86 | 16.11 | - | - | - |
PS Ratio | 4.01 | 7.16 | 7.48 | 7.88 | 9.32 | - |
PB Ratio | 1.07 | 1.97 | 1.90 | 2.10 | 2.79 | - |
P/TBV Ratio | 1.08 | 1.98 | 1.91 | 2.11 | 2.80 | - |
P/FCF Ratio | 13.64 | 21.79 | 25.15 | 30.26 | 27.27 | - |
P/OCF Ratio | 12.16 | 18.88 | 19.91 | 20.31 | 26.53 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.18 | 4.51 | 4.83 | 5.41 | 6.89 | - |
EV/EBITDA Ratio | 3.06 | 11.43 | 12.78 | 13.78 | 18.42 | - |
EV/EBIT Ratio | 3.77 | 13.84 | 15.98 | 16.75 | 22.38 | - |
EV/FCF Ratio | 4.01 | 13.73 | 16.22 | 20.78 | 20.15 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.01 | 0.02 | 0.02 | 0.06 | 0.24 |
Debt / EBITDA Ratio | 0.02 | 0.05 | 0.22 | 0.20 | 0.58 | 1.02 |
Debt / FCF Ratio | 0.03 | 0.06 | 0.28 | 0.30 | 0.63 | - |
Net Debt / Equity Ratio | -0.76 | -0.75 | -0.70 | -0.68 | -0.70 | -0.10 |
Net Debt / EBITDA Ratio | -7.36 | -6.92 | -7.34 | -6.48 | -6.23 | -0.44 |
Net Debt / FCF Ratio | -9.63 | -8.31 | -9.32 | -9.77 | -6.81 | 0.50 |
Asset Turnover | 0.27 | 0.27 | 0.25 | 0.26 | 0.39 | 0.59 |
Inventory Turnover | 2.96 | 3.20 | 2.53 | 2.49 | 2.88 | 3.42 |
Quick Ratio | 17.97 | 16.23 | 12.03 | 10.47 | 6.97 | 1.11 |
Current Ratio | 19.09 | 17.06 | 12.78 | 11.18 | 7.51 | 1.36 |
Return on Equity (ROE) | 9.19% | 10.03% | 7.39% | 10.01% | 12.59% | 20.54% |
Return on Assets (ROA) | 5.23% | 5.55% | 4.66% | 5.16% | 7.43% | 9.64% |
Return on Invested Capital (ROIC) | 28.05% | 29.14% | 22.25% | 22.46% | 25.67% | 22.70% |
Return on Capital Employed (ROCE) | 8.30% | 8.90% | 7.70% | 8.60% | 9.20% | 19.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 8.19% | 4.85% | 3.74% | 4.55% | 2.93% | - |
FCF Yield | 7.33% | 4.59% | 3.98% | 3.30% | 3.67% | - |
Buyback Yield / Dilution | -0.25% | -0.12% | 0.03% | 3.23% | -19.10% | -0.39% |